nabilone: Clinical Trials

10 trials of nabilone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 recruiting, 2 unknown. 10 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Completed 6, Recruiting 2, Unknown 2
Phase 24Completed 3, Unknown 1

Follow nabilone: new trials by email Literature Review of nabilone trials Research Report on nabilone

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder
PP-01, Nabilone, Placebo - Cannabis Withdrawal
Phase 3RecruitingPleoPharma, Inc.4202026-06-172026-10-27
Cannabinoids and an Anti-inflammatory Diet for the Treatment of Neuropathic Pain After Spinal Cord Injury
Placebo diet, Anti-inflammatory diet, Nabilone Capsules - Spinal Cord Injuries, Neuropathic Pain
Phase 3CompletedEldon Loh, MD142023-03-012025-07-22
DIalysis Symptom COntrol-Pruritus Outcome Trial
Nabilone 0.5 MG Oral Capsule, Placebo Nabilone - End Stage Renal Disease, Pruritus
Phase 3CompletedUniversity of Manitoba142022-08-022023-11-30
Nabilone for Agitation Blinded Intervention Trial
Nabilone, Placebo - Alzheimer Disease, Agitation
Phase 3RecruitingSunnybrook Health Sciences Centre1122021-02-012026-11-06
Nabilone for Non-motor Symptoms in Parkinson's Disease
Nabilone 0.25 mg - Parkinson Disease
Phase 3CompletedMedical University Innsbruck222018-08-062021-03-02
Safety and Efficacy of Nabilone in Alzheimer's Disease
Nabilone, Placebo - Alzheimer Disease, Agitation
Phase 2 / Phase 3CompletedSunnybrook Health Sciences Centre382015-01-012020-06-25
Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients
Nabilone, Placebo - Non-Small Cell Lung Cancer, Anorexia
Phase 2 / Phase 3UnknownInstituto Nacional de Cancerologia de Mexico782014-12-012016-08-31
Nabilone for Cannabis Dependence: A Pilot Study
Nabilone, Placebo - Cannabis Dependence, Marijuana Dependence
Phase 2 / Phase 3CompletedMclean Hospital842010-06-012018-06-01
Nabilone & Marijuana Addiction
Cesemat - Marijuana Smoking
Phase 2 / Phase 3CompletedUniversity of British Columbia352009-06-012011-02-17
Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic Pain
Nabilone, flexible dosing - Diabetic Neuropathies
Phase 3UnknownUniversity of Calgary602008-01-012009-12-18

Conditions studied

Marijuana Abuse (3)  ·  Alzheimer Disease (2)  ·  Neuralgia (2)  ·  Pain (2)  ·  Psychomotor Agitation (2)  ·  Anorexia (1)  ·  Cachexia (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Diabetic Neuropathies (1)  ·  Kidney Failure, Chronic (1)  ·  Marijuana Smoking (1)  ·  Parkinson Disease (1)  ·  Pruritus (1)  ·  Spinal Cord Injuries (1)  ·  Weight Loss (1)

Sponsors

Sunnybrook Health Sciences Centre (2)  ·  Eldon Loh, MD (1)  ·  Instituto Nacional de Cancerologia de Mexico (1)  ·  Mclean Hospital (1)  ·  Medical University Innsbruck (1)  ·  PleoPharma, Inc. (1)  ·  University of British Columbia (1)  ·  University of Calgary (1)  ·  University of Manitoba (1)

Countries

Canada (6)  ·  United States (2)  ·  Austria (1)  ·  Mexico (1)

Top investigators

Cory Toth, MD (1)  ·  David Collister, MD, PhD (1)  ·  David Ditor, MD (1)  ·  Eldon Loh, MD (1)  ·  Giovanni Marotta, MD (1)  ·  Jay Constantine, MD (1)  ·  Kevin P Hill, MD, MHS (1)  ·  Krista L. Lanctot, PhD (1)  ·  Nathan Herrmann, MD (1)  ·  Oscar Arrieta, MD M Sc (1)  ·  Shaohua Lu, MD (1)

Results publications

PMID 11786587, PMID 12457271, PMID 15778874, PMID 15857739, PMID 16376734, PMID 16408219, PMID 1666930, PMID 16849753, PMID 17589370, PMID 18402303, PMID 21343383, PMID 29550881, PMID 30753761, PMID 31182351, PMID 31322567, PMID 31547752, PMID 34532852, PMID 3774823, PMID 8035251, PMID 8558188

NIH funding

K99DA029115 (1), U01DA066079 (1)